SCHEMBL707702

SCHEMBL707702

c1ccc(COc2ccc3cc[nH]c3c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.62
NSD2 O96028 1/20 0.58
ABL1 P00519 1/20 0.58
PPARG P37231 1/20 0.58
RIN1 Q13671 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
NCOR2 Q9Y618 1/20 0.58
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
CDK4 P11802 1/20 0.53
CCND1 P24385 1/20 0.53
POLB P06746 1/20 0.53
MAPK1 P28482 1/20 0.53
MAPT P10636 2/20 0.53
APP P05067 1/20 0.53
MAOB P27338 6/20 0.52
ACHE P22303 1/20 0.52
CYP3A4 P08684 1/20 0.51
IMPDH2 P12268 1/20 0.51
CTSV O60911 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29463389 1.00 ALOX5 (0.62) ALOX5NSD2ABL1PPARGRIN1
Acetic Acid Methyl Ester SCHEMBL6664145 0.88 APP (0.60) ALOX5NSD2ABL1PPARGRIN1
SCHEMBL329575 0.87 ALOX5 (0.62) ALOX5NSD2ABL1PPARGRIN1
Indole SCHEMBL15320969 0.86 ALOX5 (0.61) ALOX5NSD2ABL1PPARGRIN1
Ethoxycarbonyl Group SCHEMBL27720865 0.86 APP (0.51) ALOX5NSD2ABL1PPARGRIN1
SCHEMBL9265126 0.84 AHR (0.54) MEN1KMT2APOLBMAPK1APP
SCHEMBL9023367 0.84 MEN1 (0.54) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL31464043 0.84 POLB (0.68) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL18640278 0.84 POLB (0.68) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL9735601 0.82 MEN1 (0.48) ALOX5MEN1KMT2APOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223273-A2 COMPOSITIONS AND METHODS FOR MODULATION OF ANTIBODY ACTIVITY INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER (US) 2020-11-05 WO claimed
US-7122674-B2 Process for preparing high-purity hydroxyindolylglyoxylamides ELBION AG (DE) 2006-10-17 US claimed
CN-1275942-C Benzyloxy substituted indole compound and its analog and their production method and application UNIV FUDAN (CN) 2006-09-20 CN claimed
US-20040063939-A1 Process for preparing high-purity hydroxyindolylglyoxylamides ELBION AG (DE) 2004-04-01 US claimed
EP-3894390-B1 SYNTHESIS OF (S)-6-HYDROXYTRYPTOPHAN AND DERIVATIVES THEREOF HEIDELBERG PHARMA RES GMBH (DE) 2026-05-20 EP disclosed
US-12631644-B2 Biomarker panel targeted to diseases due to multifactorial ontology of glycocalyx disruption ARTEREZ, INC. (US) 2026-05-19 US disclosed
US-12599584-B2 Indoline derivatives, compositions comprising them and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2026-04-14 US disclosed
US-12378196-B2 Synthesis of (S)-6-hydroxytryptophan and derivatives thereof HEIDELBERG PHARMA RESEARCH GMBH (DE) 2025-08-05 US disclosed
US-20250179018-A1 SYNTHESIS OF (S)-6-HYDROXYTRYPTOPHAN AND DERIVATIVES THEREOF HEIDELBERG PHARMA RESEARCH GMBH (DE) 2025-06-05 US disclosed
CN-113166057-B Synthesis of (S) -6-hydroxytryptophan and derivatives thereof 海德堡医药研究有限责任公司 2024-12-31 CN disclosed
US-12139459-B2 Enhancer of fertilization function of sperm TOHOKU UNIVERSITY (JP) 2024-11-12 US disclosed
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2024-08-27 US disclosed
WO-1993001813-A1 PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1993-02-04 WO disclosed
WO-1992014732-A1 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1992-09-03 WO disclosed
EP-0499987-A1 Platelet activating factor antagonists ABBOTT LABORATORIES (US) 1992-08-26 EP disclosed
US-5120749-A Treatment of anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellulosr immunity, parturtition, fetal lung maturation, and cellular differentiation ABBOTT LABORATORIES (US) 1992-06-09 US disclosed
WO-1992004321-A1 SUBSTITUTED BICYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-03-19 WO disclosed
US-5034015-A Fade resistant hair dyes with better coloring ability L'OREAL (FR) 1991-07-23 US disclosed
US-4866084-A EXTRACTED FROM SPONGES HARBOR BRANCH OCEANOGRAPHIC INSTITUTION, INC. (US) 1989-09-12 US disclosed
CN-87107372-A Process for preparing 5, 6-dihydroxyindoles and 3-alkyl derivatives and intermediate compounds thereof 1988-08-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063939-A1 Process for preparing high-purity hydroxyindolylglyoxylamides HAAO, HPD, GRHPR ALOX5 470/4885NSD2 3223/4885ABL1 1144/4885
US-12631644-B2 Biomarker panel targeted to diseases due to multifactorial ontology of glycocalyx disruption PGF, FGB, LGALS3BP ALOX5 1412/4885NSD2 4851/4885ABL1 2747/4885
US-12139459-B2 Enhancer of fertilization function of sperm CATSPER1, NASP, ZP1 ALOX5 2382/4885NSD2 3078/4885ABL1 4835/4885
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 ALOX5 1009/4885NSD2 1552/4885ABL1 2885/4885
US-20250179018-A1 SYNTHESIS OF (S)-6-HYDROXYTRYPTOPHAN AND DERIVATIVES THEREOF AANAT, HNMT, HTR6 ALOX5 955/4885NSD2 1703/4885ABL1 929/4885
US-12378196-B2 Synthesis of (S)-6-hydroxytryptophan and derivatives thereof AANAT, HNMT, HTR6 ALOX5 695/4885NSD2 1998/4885ABL1 1494/4885
US-12599584-B2 Indoline derivatives, compositions comprising them and uses thereof IL6, TNF, IDO1 ALOX5 163/4885NSD2 4634/4885ABL1 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.